Tradition Wealth Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-73
Closed -$8K 1396
2023
Q3
$8K Hold
73
﹤0.01% 1082
2023
Q2
$8K Hold
73
﹤0.01% 1111
2023
Q1
$8K Buy
+73
New +$8.07K ﹤0.01% 1061
2022
Q3
Sell
-2,513
Closed -$200K 1234
2022
Q2
$200K Hold
2,513
0.03% 260
2022
Q1
$264K Hold
2,513
0.03% 258
2021
Q4
$271K Hold
2,513
0.03% 259
2021
Q3
$275K Hold
2,513
0.04% 235
2021
Q2
$235K Buy
+2,513
New +$231K 0.04% 261

Other funds holding HZNP

Tradition Wealth Management's HZNP Position: Q4 2023 in Review

Tradition Wealth Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 73 shares — an estimated $8K sold.

Tradition Wealth Management first reported a position in HZNP in Q2 2021 and held it in 8 quarters. The position peaked at $275K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Tradition Wealth Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Tradition Wealth Management sold 73 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $8K.
  • Tradition Wealth Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2021 and held it in 8 quarters.
  • Tradition Wealth Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $275K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Tradition Wealth Management's 13F filing for Q4 2023, filed 12 Feb 2024.